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Abstract: Chorea is a rare manifestation of systemic lupus erythematosus (SLE). We report on a young patient with chorea who was 
diagnosed initially with rheumatic fever. Follow up and further evaluation confirmed the diagnosis of SLE and anti-phospholipid 
syndrome. Of special interest were the negative antiphospholipid (aPL) antibodies and the initial diagnosis of rheumatic fever which 
is still not uncommon problem in our region. The rarity of such presentation with joint and non specific increase of antistreptolysin O 
(ASO) titer might be the factors that led to an incorrect diagnosis. Early diagnosis and treatment of SLE and anti-phospholipid syndrome 
are very crucial and should be considered with such presentation.
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Introduction
Systemic  lupus  erythematosus  (SLE)  affects  many 
organ systems, including the central and peripheral 
nervous  systems  and  muscles.1,2  Movement  disor-
ders were not included in the American College of 
Rheumatology (ACR) criteria.3 Chorea has been seen 
in fewer 4% of patients.4 In this case report, the   chorea 
was the first manifestation in this SLE patient.
case Report
A 15-year old right-handed female was presented with 
a two day history of involuntary movements affected 
the right side of her body, which had been noted pri-
marily by her mother. She also had a history of mul-
tiple joint pain and of upper respiratory tract infection 
two weeks prior to her symptoms where she received 
7 days of Amoxicillin. She had denied any history of 
fever or shortness of breath. She was not on any med-
ication. There was no family history of movement 
disorders, dementia or psychiatric illness.
The patient reported no difficulty with speech, bal-
ance or autonomic function, and there was no history 
of psychiatric illness or cognitive deterioration. There 
was also no history of involuntary movements dur-
ing childhood or pregnancy, and the patient was not 
aware of any past history of rheumatic fever.
General physical examination was normal apart 
from mild fever (37.7 °C) and the presence of joint 
tenderness of the knees, hands and feet. Neurological 
examination  revealed  normal  extra-ocular  move-
ments,  and  normal  motor,  sensory  and  cerebellar 
testing. Reflexes were physiological and symmetrical. 
The patient’s choreic movements were moderate in 
severity, and predominantly distal, affecting the right 
arm  and  leg.  The  cardiovascular  system  and  skin 
examination were unremarkable.
Investigations  including  renal  and  liver  func-
tion,    complete  blood  count  were  all  unremarkable. 
Antistreptolysin O (ASO) titer was mildly elevated, 
ECG & echocardiogram was normal. Brain MRI was 
normal. Erythrocyte sedimentation rate, activated par-
tial thromboplastin time, as well as levels of glucose, 
thyroid-stimulating  hormone,  thyroid  antibodies, 
electrolytes,  calcium,  magnesium,  phosphorus  were 
normal.
The patient was admitted to the hospital with work-
ing diagnosis of rheumatic fever. She was treated with 
salicylates, single dose of intramuscular benzathine 
penicillin G and Haloperidol.
Two  weeks  later,  throat  swab  culture,  serum 
vitamin E and ceruloplasmin, were all   unremarkable 
but  involuntary  movements  persisted.  Therefore, 
  Antinuclear  Antibody  (ANA)  and  anti-double-
stranded (ds) DNA antibody titers were carried out 
which were found to be elevated (1/640; 36.5 IU/mL, 
normal , 10 IU/mL respectively). The anti-Sm and   
anti-cardiolipin (aCL) antibodies were both negative. 
Repeated ASO titer remained the same as before.
At this stage, because the results of investigations 
were highly suggestive of SLE, 24 hours urine collec-
tion of proteins showed 2300 mg/day, kidney biopsy 
was  done  and  showed  glomerulonephritis  (WHO 
class 4). At that time, she was started on Cellcept 
2 gm/day and prednisolone.
Six  months  after  treatment,  she  had  complete 
remission of lupus nephritis but remained with mild 
choreo-athetotic movement. The repeated IgM aCL 
antibodies were positive.
Discussion
Rheumatic fever is the most common cause of acquired 
chorea in the young.5,6 No single specific laboratory 
test can confirm this diagnosis.7–9 The modified Jones 
criteria which are less sensitive tend to make cases 
more easily missed in high-prevalence areas.10,11 This 
is why this patient was treated as having rheumatic 
fever. High titer of  ANA on this patient alerted the 
doctors that SLE should be considered as a cause of 
such presentation.
Chorea, although rare, is a well recognized neu-
rological manifestation of SLE.12,13 It usually occurs 
during the course of disease but may be the present-
ing feature of SLE.14 In the retrospective study of 
central nervous system disease in 105 patients with 
SLE, Khamashta et al15 observed two patients with 
chorea as a presenting feature of their illness. In this 
case report, chorea was also the initial manifestation 
of SLE, though misdiagnosed as rheumatic fever.
Most reports show an association between cho-
rea  and  antiphospholipid  (aPL)  antibodies  in  SLE 
patients.16,17 In this patient, the aPL antibodies were 
negative initially but turned out to be positive six 
months  after  presentation. The  aPL  antibodies  are 
unlikely  to  be  positive  in  patients  with  rheumatic publish with Libertas Academica and 
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fever  as  previously  mentioned  by  Asherson  and 
associates.18
The chorea in SLE is immune-mediated   problem 
and associated with appearance of lupus anticoagu-
lants and aCL antibodies in the serum.19 Even normal 
titers of these antibodies at the time of presentation, 
however, do not rule out the disease. Baizabal-Carvallo 
and  colleagues16  in  their  retrospective  review  ini-
tially observed negative aPL at the onset of chorea. 
Later on, IgM aCL antibodies became positive. This 
case report also reveals elevated aCL antibodies six 
months after the occurrence of chorea in SLE.
conclusion
The non-sensitive criteria of Rheumatic fever should 
make the physician alert to other possible causes of 
chorea like SLE and antiphospholipid syndrome. The 
aPL antibodies should be repeated periodically even 
if it is negative at the time of presentation.
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